- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00764569
The Investigation of a Fluorescence/Elastic Scattering Spectroscopy (F-ESS) Device for Oral Tissue Characterization
October 28, 2022 updated by: Beckman Laser Institute and Medical Center, University of California, Irvine
a Non-invasive Device for the Detection, Diagnosis and Screening of Oral Pathology
The overall objective of this work is to identify changes in the optical properties of oral tissues to develop a non-invasive tool for the detection, diagnosis and screening of oral pathology so that treatment can be provided at the earliest possible time.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Specifically, we will be obtaining optical spectroscopic data using a fiber optic contact probe that exploits elastic-scattering spectroscopy and fluorescence spectroscopy.
Both of these technique have independently shown to provide signatures for the onset of cancer, with varied success.
The purpose of this effort is to combine the two techniques and develop and understanding of the signatures obtained in both normal and abnormal oral tissue with simultaneous collection of these optical signatures.
Study Type
Observational
Enrollment (Actual)
77
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Irvine, California, United States, 92612
- Beckman Laser Institute Medical Clinic
-
Irvine, California, United States, 92612
- UCI student health center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
community sample
Description
Inclusion Criteria:
- adult over 18 years of age
Exclusion Criteria:
- younger than 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Oral Tissue measurement
Fluorescence/Elastic Scattering Spectroscopy Oral tissue measurement
|
Fluorescence/Elastic Scattering Spectroscopy Oral tissue measurement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnostic Tool
Time Frame: 4 weeks
|
Fluorescence/Elastic Scattering Spectroscopy Oral tissue measurement
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Petra Wilder-Smith, DDS, PhD, Beckman Laser Institute University of California Irvine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
October 1, 2008
First Submitted That Met QC Criteria
October 1, 2008
First Posted (Estimate)
October 2, 2008
Study Record Updates
Last Update Posted (Actual)
November 1, 2022
Last Update Submitted That Met QC Criteria
October 28, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20086355
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Other Lesions of Oral Mucosa
-
University Hospital, BordeauxCompletedPrecancerous Lesions of the Oral MucosaFrance
-
Centre Hospitalier Universitaire DijonCompletedCancerous Lesions of the Oral CavityFrance
-
Khon Kaen UniversityNot yet recruitingOral MucosaThailand
-
Rutgers, The State University of New JerseyTerminatedOther Biomechanical Lesions of Upper ExtremityUnited States
-
Pharma Power Biotec Co., Ltd.CompletedA Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous LesionErythroleukoplakia of Mouth | Verrucous Hyperplasia of Oral MucosaTaiwan
-
M.D. Anderson Cancer CenterNational Institute of Dental and Craniofacial Research (NIDCR)Recruiting
-
Nuno MoraisInstituto Politécnico de LeiriaCompletedOther Lesions of Median NervePortugal
-
October 6 UniversityCompleted
-
University of Wisconsin, MadisonTerminatedNeoplasm | Transplant-Related Disorder | Oral MucosaUnited States
-
Ain Shams UniversityRecruitingOral Potentially Malignant LesionsEgypt
Clinical Trials on Fluorescence/Elastic Scattering Spectroscopy
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous ConditionUnited States, Canada
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Healthy, no Evidence of DiseaseUnited States
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)CompletedCervical Cancer | Precancerous Condition
-
University of Wisconsin, MadisonCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Vanderbilt UniversityNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Eye Institute (NEI)Completed
-
Hospices Civils de LyonCompletedLow Grade Glioma (LGG) | High Grade Glioma (HGG)France
-
Shanghai Jiao Tong University School of MedicineShanghai Photonic View Technology Co., Ltd.Not yet recruitingDiabetes Mellitus | Medical Device